Tag Archives: Morningstar

Amgen, Allergan get nod for Avastin biosim; FDA’s Gottlieb making good on vow to hasten generic approvals, catch the EU.

The News: Amgen Inc. (Thousand Oaks CA) and Allergan PLC (Dublin IRL) said Thursday (September 14, 2017) that the Food and Drug Administration has approved their biosimilar version of Roche… Read more »

Slumbering giant Lilly to cut more jobs, take a $1.2-billion hit to bolster R&D pipeline.

The News: Eli Lilly & Co. (Indianapolis IN) last week said it would lay off about 8% of its employees as the drugmaker, which has suffered setbacks over the past… Read more »

Germany’s Merck puts consumer drugs business up for sale; does this signal a last-ditch shot at M&A or just shoring up existing pipeline?

The News: Merck KGaA (Darmstadt DEU) put its consumer-health unit on the block Tuesday (September 5, 2017) in a move that will focus its healthcare activities on the riskier business… Read more »

IPO Alert: Actelion founders launch startup on $1.5 billion J&J payday: call your broker, soon

Steve’s Take: If ever there was a “story” biotech IPO worth grabbing even a tiny piece of, this is it. First, the story: Two decades ago Jean-Paul and Martine Clozel… Read more »

Federal judge blocks $54-billion Anthem, Cigna merger; judiciary giving notice who’s boss in court

The News: A federal judge last week (February 6, 2017) blocked health insurer Anthem Inc. (Indianapolis IN) from acquiring rival Cigna Corp. (Bloomfield CT), the second court ruling in recent… Read more »

Community Health Throwing in Towel, Say Sources; Going Private an Option?

Community Health Systems Inc. (Franklin TN), the troubled hospital operator, is exploring a possible sale of its business, Bloomberg News reported, citing “people with knowledge of the matter.” The company… Read more »